Liwei S. has extensive experience in statistical programming and data science across various leading pharmaceutical companies. Currently serving as Executive Director and Head of Statistical Programming at Theravance Biopharma US, Inc. since June 2016, Liwei provides leadership in analytical programming across clinical trials and medical research. Prior roles include CEO and Founder of New Horizon Research Corp, Director of Statistical Programming at Amylin Pharmaceuticals, and Global Head of Clinical Programming for Pfizer’s BioTherapeutic Research Unit. With a career that began in 1996, Liwei has consistently demonstrated expertise in managing statistical programming functions, facilitating high-quality data presentation for clinical development, and leading teams in compliance with industry standards.
This person is not in the org chart
This person is not in any teams
This person is not in any offices